cough-cold-icon
Bood thinner relevant medicine
Sir/Madam Apixoban 2.5 mg 1 month) or Dibigo 110 mg (2 weeks) or Rivalto 20 mg( (14 days) Out of these medicines, which is more appropriate and plz mention reason also. Age 75 years, female Back ground: Post covid(after 40 days) D dimer report is 1078(Normal reference Is 0-500range) Thank you
51 Views v

Answers (3)

20000+ health queries resolved in last month
Care AI Shimmer
Depends on the clinical scenario and the patients symptoms and risk factors...not on the lab report!!! kindly do a consultation with a pulmonologist to know more bout ur case and further management!!!!
Answered
Flag this Answer
Flag this answer
Let others know if this answer was helpful
Was this answer helpful?

Didn't find the answer you are looking for?

Talk to experienced doctor online and get your health questions answered in just 5 minutes.

doctor profile image doctor profile image doctor profile image doctor profile image +199
Consult with a doctor
Online now
Do take doctor consultation
Answered
Flag this Answer
Flag this answer
Let others know if this answer was helpful
Was this answer helpful?
Consult your treating doctor for the same
Answered
Flag this Answer
Flag this answer
Let others know if this answer was helpful
Was this answer helpful?
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.